Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma

Journal of Surgical Oncology

Volumn 110, Issue 6, 2014, Pages 764-769

  Niwa, Yukiko ^a   Yamada, Suguru ^a   Koike, Masahiko ^a   Kanda, Mitsuro ^a   Fujii, Tsutomu ^a   Nakayama, Goro ^a   Sugimoto, Hiroyuki ^a   Nomoto, Shuji ^a   Fujiwara, Michitaka ^a   Kodera, Yasuhiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epithelial to mesenchymal transition; Esophageal cancer; Prognosis; Tumor budding

Indexed keywords

UVOMORULIN; VIMENTIN; CADHERIN; MESSENGER RNA;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR BUDDING; AGED; ESOPHAGUS TUMOR; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIMENTIN;

EID: 84912011059     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23694     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Ando N, Ozawa S, Kitagawa Y, et al.: Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225-232.
4. Radisky DC: Epithelial-mesenchymal transition. J Cell Sci 2005;118:4325-4326.
5. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-746.
6. Yang J, Mani SA, Weinberg RA: Exploring a new twist on tumor metastasis. Cancer Res 2006;66:4549-4552.
7. Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-273.
8. Jechlinger M, Grunert S, Tamir IH, et al.: Expression profiling of epithelial plasticity in tumor progression. Oncogene 2003;22:7155-7169.
9. Larue L, Bellacosa A: Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005;24:7443-7454.
10. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
11. Brabletz T, Jung A, Spaderna S, et al.: Opinion: Migrating cancer stem cells-An integrated concept of malignant tumour progression. Nat Rev Cancer 2005;5:744-749.
12. Gotzmann J, Mikula M, Eger A, et al.: Molecular aspects of epithelial cell plasticity: Implications for local tumor invasion and metastasis. Mutat Res 2004;566:9-20.
13. Lee JM, Dedhar S, Kalluri R, et al.: The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 2006;172:973-981.
14. Cai Z, Zhou Y, Lei T, et al.: Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells. Cancer 2009;115:36-48.
15. Isohata N, Aoyagi K, Mabuchi T, et al.: Hedgehog and epithelialmesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer 2009;125:1212-1221.
16. Natsuizaka M, Ohashi S, Wong GS, et al.: Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 2010;31:1344-1353.
17. Hase K, Shatney C, Johnson D, et al.: Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-635.
18. Ueno H, Murphy J, Jass JR, et al.: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopa-thology 2002;40:127-132.
19. Ueno H, Price AB, Wilkinson KH, et al.: A new prognostic staging system for rectal cancer. Ann Surg 2004;240:832-839.
20. Koike M, Kodera Y, Itoh Y, et al.: Multivariate analysis of the pathologic features of esophageal squamous cell cancer: Tumor budding is a significant independent prognostic factor. Ann Surg Oncol 2008;15:1977-1982.
21. Teramoto H, Koike M, Tanaka C, et al.: Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagus. J Surg Oncol 2013;108:42-46.
22. Guarino M, Rubino B, Ballabio G: The role of epithelialmesenchymal transition in cancer pathology. Pathology 2007;39: 305-318.
23. Yamada S, Fuchs BC, Fujii T, et al.: Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 2013; 154:946-954.
24. Sobin LH, Gospodarowicz MK, Wittekind C: TNM classification of malignant tumours, 7th edition. Hoboken, New Jersey: Wiley; 2011.
25. Hamilton SR, Aaltonen LA: Pathology and genetics of tumours of the digestive system. Lyon, France: IARC Press; 2000.
26. Murai T, Yamada S, Fuchs BC, et al.: Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer. J Surg Oncol 2014;109:684-689.
27. Sudo T, Iwaya T, Nishida N, et al.: Expression of mesenchymal markers vimentin and fibronectin: The clinical significance in esophageal squamous cell carcinoma. Ann Surg Oncol 2013;20:324-335.
28. Prall F: Tumour budding in colorectal carcinoma. Histopathology 2007;50:151-162.
29. Masugi Y, Yamazaki K, Hibi T, et al.: Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. Hum Pathol 2010;41:1061-1068.
30. Markl B, Arnholdt HM: Prognostic significance of tumor budding in gastrointestinal tumors. Expert Rev Anticancer Ther 2011;11: 1521-1533.
31. Koyuncuoglu M, Okyay E, Saatli B, et al.: Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer? Gynecol Oncol 2012;125:208-213.
32. Lugli A, Karamitopoulou E, Zlobec I: Tumour budding: A promising parameter in colorectal cancer. Br J Cancer 2012;106: 1713-1717.
33. Jin H, Morohashi S, Sato F, et al.: Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res 2010;31:105-112.
34. Wang C, Huang H, Huang Z, et al.: Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 2011;40:545-551.
35. Wang X, Zhang J, Fan M, et al.: The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: Immunohis-tochemical and RT-PCR analysis with clinicopathological correlation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107: 547-554.